Cases in Methamphetamine-Associated Psychosis

Cost: Free registration.

This webinar will be presented by:

Dr. Julius Elefante, MD


Presentations will be followed by a discussion where participants will have the opportunity to ask questions and receive real-time responses from presenters.

Following the session, attendees will be able to:

  • Describe the prevalence of methamphetamine-induced psychosis
  • Explore the relationship between methamphetamine-induced psychosis and primary psychotic disorders
  • Provide an overview of the management of methamphetamine-induced psychosis

Additional Information:

  • Presentations will be followed by a discussion where participants will have the opportunity to ask questions and receive real-time responses from presenters.
  • This event is accredited by the College of Family Physicians of Canada and the British Columbia Chapter for up to 1 Mainpro+ credit.
  • Please note the session will be recorded and available after the event on the BC-CfE's website at: https://bccfe.ca/video-category/webinars/.

If you have any questions regarding this event, please contact BC-CfE’s Education and Training team at: education@bccfe.ca. We are looking forward to seeing you there!

Event Details

Days
Hours
Minutes
Seconds
Start Date
End Date
Event Category
Registration
Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025